Progyny, Inc. Files Q1 2025 10-Q
Ticker: PGNY · Form: 10-Q · Filed: May 9, 2025 · CIK: 1551306
| Field | Detail |
|---|---|
| Company | Progyny, Inc. (PGNY) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Progyny's Q1 2025 10-Q is in. Check financials for latest performance.
AI Summary
Progyny, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures relevant to investors are presented, reflecting the company's ongoing business activities and strategic positioning in the health and allied services sector.
Why It Matters
This filing provides investors with the latest financial performance data for Progyny, Inc. for the first quarter of 2025, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks highlighted.
Key Players & Entities
- Progyny, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250509 (date) — Filing date
- Auxogyn, Inc. (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 9, 2025.
What was Progyny, Inc.'s former company name?
Progyny, Inc.'s former company names included Auxogyn, Inc. and Auxogyn Inc.
What is Progyny, Inc.'s fiscal year end?
Progyny, Inc.'s fiscal year ends on December 31.
What is Progyny, Inc.'s business address?
Progyny, Inc.'s business address is 1359 Broadway, 2nd Floor, New York, NY 10018.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding Progyny, Inc. (PGNY).